Literature DB >> 18433382

Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases.

Ozlem Ozer Yücel1, Ezel Berker, Semra Gariboğlu, Harika Otlu.   

Abstract

OBJECTIVES: The balance between pro-inflammatory and anti-inflammatory cytokines may be crucial for determining the immunopathology of gingivitis (G) and periodontitis. This study aimed to analyse interleukin-1beta (IL-1beta), IL-11 and IL-12 levels in gingival crevicular fluid (GCF) of patients with G and chronic periodontitis (CP).
MATERIAL AND METHODS: Fourty subjects including 12 CP, 14 G and 14 controls (C) were enrolled. GCF samples were collected from six maxillary sites per patient and analysed for IL-1beta, IL-11 and IL-12 by an enzyme-linked immunosorbent assay.
RESULTS: Significantly lower concentrations of IL-11 were detected in CP compared with both G and C groups (p<0.05). The CP group had a significantly higher total amount of IL-12 and IL-1beta compared with the C group (p<0.05). The IL-11:IL-1beta cytokine ratio was higher in both G and C groups compared with the CP group. The IL-11:IL-1beta ratio became progressively lower with increasing probing depth (p<0.01).
CONCLUSIONS: Our data showed that IL-11 levels are significantly decreased in GCF from sites with periodontitis compared with G and healthy sites. Because of the possible preventive effect of IL-11 on inflammation, IL-11 may be an important factor in the therapeutic modulation of periodontal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433382     DOI: 10.1111/j.1600-051X.2008.01212.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  15 in total

1.  Effect of periodontal therapy on salivary interleukin-12 levels in chronic periodontitis.

Authors:  Anamika Sharma; B P Khattak; S Naagtilak; Ganesh Singh; Tanveer Bano
Journal:  J Clin Diagn Res       Date:  2014-10-20

Review 2.  B cells as under-appreciated mediators of non-auto-immune inflammatory disease.

Authors:  Barbara S Nikolajczyk
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

3.  Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease.

Authors:  Pamela Sparks Stein; Michelle J Steffen; Charles Smith; Gregory Jicha; Jeffrey L Ebersole; Erin Abner; Dolph Dawson
Journal:  Alzheimers Dement       Date:  2012-05       Impact factor: 21.566

Review 4.  Human and herpesvirus microRNAs in periodontal disease.

Authors:  Afsar R Naqvi; Jørgen Slots
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 12.239

5.  IL-11 regulates autoimmune demyelination.

Authors:  Blake T Gurfein; Yueting Zhang; Carolina B López; Azeb Tadesse Argaw; Andleeb Zameer; Thomas M Moran; Gareth R John
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

6.  Interleukin-11 - its role in the vicious cycle of inflammation, periodontitis and diabetes: A clinicobiochemical cross-sectional study.

Authors:  Rohit Prasad; Aganashini Suchetha; Puzhankara Lakshmi; Mundinamane Basawalingappa Darshan; Sokke Mallikarjuna Apoorva; Gulabdas Bharwani Ashit
Journal:  J Indian Soc Periodontol       Date:  2015 Mar-Apr

Review 7.  Salivary and crevicular fluid interleukins in gingivitis.

Authors:  Montserrat Boronat-Catalá; Montserrat Catalá-Pizarro; José V Bagán Sebastián
Journal:  J Clin Exp Dent       Date:  2014-04-01

8.  IL-17 and IL-11 GCF levels in aggressive and chronic periodontitis patients: relation to PCR bacterial detection.

Authors:  Olfat G Shaker; Noha A Ghallab
Journal:  Mediators Inflamm       Date:  2012-11-26       Impact factor: 4.711

Review 9.  Inflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic Review.

Authors:  D C B Cortela; A L de Souza Junior; M C L Virmond; E Ignotti
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

10.  Emdogain-regulated gene expression in palatal fibroblasts requires TGF-βRI kinase signaling.

Authors:  Alexandra Stähli; Dieter Bosshardt; Anton Sculean; Reinhard Gruber
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.